OnCo

Sign in to keep your watchlist

Your watched pages live in this browser. Sign in with an email link and OnCo keeps the same list on every device you use. Only your email address and your watchlist are stored.

Appointment sheet: Early gastric cancer

One page to bring and write on: your details, the questions for Early gastric cancer plus your own, the words you may hear, what to bring, the treatments the standard of care names, and room for the answers and agreed next steps. What you type stays in this browser. Print it or save it as a PDF. New to all this? Start with the first 60 days. Orientation, not medical advice.

Tick the questions to print

All of this cancer's questions start ticked. Untick what does not apply; ticks are kept in this browser. .

Your own questions

Shared with the prep pack, so questions you add there appear here too.

Print or save as PDF

Use (or Ctrl+P, Cmd+P on a Mac). To keep a copy, choose Save as PDF as the destination in the print dialog. Only the sheet prints; the controls stay on screen. Your typed notes print where you typed them; empty fields print as ruled lines to write on.

Appointment sheet

Early gastric cancer

Prepared with OnCo (onco.cc/prep/early-gastric-cancer/). Orientation, not medical advice; your team knows your case.

My details

Name
Date of appointment
Hospital and clinician
Who is coming with me

What I know, what is unclear, changes to discuss

Saved in this browser
What I know so far
What is unclear to me
Changes since last time

My questions

13 on the sheet
Newly diagnosed
  1. 1.What is my exact diagnosis, stage, and grade, and which tests established them?
  2. 2.Which biomarkers have been tested on my tumour (for example Depth of invasion, ulceration and size, Differentiated versus undifferentiated histology, Lymphovascular invasion and margin status on the resected specimen, Helicobacter pylori status, Intestinal metaplasia and atrophy extentfor surveillance intervals), and what were the results?
  3. 3.Which subtype is my cancer, and does that change the recommended treatment?
  4. 4.Is germline (inherited) genetic testing recommended for me or my family?
Within endoscopic criteria
  1. 5.For my situation (within endoscopic criteria), which of the standard options do you recommend and why?
Non-curative resection or outside criteria
  1. 6.For my situation (non-curative resection or outside criteria), which of the standard options do you recommend and why?
After resection
  1. 7.For my situation (after resection), which of the standard options do you recommend and why?
Screening
  1. 8.For my situation (screening), which of the standard options do you recommend and why?
Any stage
  1. 9.Are there clinical trials I could join, for example of Endoscopic resection (EMR / ESD), Robotic & minimally invasive surgery, Liquid biopsy (ctDNA), MRD / molecular residual disease testing?
  2. 10.Would a second opinion at a high-volume centre change anything, and can you help arrange it?
  3. 11.What supportive care (symptom control, nutrition, exercise, mental health, financial help) is available from the start?
  4. 12.I read that “Western countries have no screening and diagnose most gastric cancers late”. How does that affect my plan?
  5. 13.I read that “Predicting nodal spread in submucosal tumours to spare more patients surgery”. How does that affect my plan?

The words I may hear

  • Screening: Testing people who have no symptoms to catch cancer, or its precursors, early enough to cure.
  • Gastrectomy: Removing part (subtotal) or all (total) of the stomach for stomach cancer, with the bowel joined to what remains.
  • Lymphadenectomy (lymph node dissection): Surgically removing the lymph nodes that drain a tumour, both to stage the cancer and to clear any spread.
  • Endoscopy (EGD, EUS, ERCP): Looking inside a hollow organ with a camera on a flexible tube, taking biopsies and sometimes treating on the spot.

Tests and results to bring

Biomarker results to ask for: Depth of invasion, ulceration and size (endoscopic resection criteria), Differentiated versus undifferentiated histology, Lymphovascular invasion and margin status on the resected specimen (eCura risk), Helicobacter pylori status, Intestinal metaplasia and atrophy extent (Kimura-Takemoto, OLGA) for surveillance intervals.

Scans and tests linked to this cancer: Endoscopic resection (EMR / ESD), Liquid biopsy (ctDNA), MRD / molecular residual disease testing.

Bring copies of scan reports, pathology and blood results, and a list of every medicine and supplement.

The treatments I may be offered

From the standard of care recorded for this cancer; which apply depends on your stage and biomarkers. Ask which the team recommends and why.

Answers and next steps

Saved in this browser
What I was told
Agreed next steps, dates and who to call